These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10396588)

  • 21. The comparative efficacy and safety of teicoplanin and vancomycin.
    Cobo J; Fortún J
    J Antimicrob Chemother; 1996 Dec; 38(6):1113-4. PubMed ID: 9023665
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors.
    Kim BK; Kim JH; Sohn KH; Kim JY; Chang YS; Kim SH
    Korean J Intern Med; 2020 May; 35(3):714-722. PubMed ID: 31722513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergic cross-reactivity to teicoplanin and vancomycin.
    Davenport A
    Nephron; 1993; 63(4):482. PubMed ID: 8459893
    [No Abstract]   [Full Text] [Related]  

  • 24. Teicoplanin versus vancomycin for proven or suspected infection.
    Cavalcanti AB; Goncalves AR; Almeida CS; Bugano DD; Silva E
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007022. PubMed ID: 20556772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C; Glasmacher A; Arns A; Mühling A; Orlopp K; Marklein G; Von Lilienfeld-Toal M
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
    Zeckel ML
    J Chemother; 1997 Oct; 9(5):311-31; discussion 332-5. PubMed ID: 9373787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.
    Kato-Hayashi H; Niwa T; Ohata K; Harada S; Matsumoto T; Kitagawa J; Tsurumi H; Suzuki A
    J Clin Pharm Ther; 2019 Dec; 44(6):888-894. PubMed ID: 31373043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis.
    Webster A; Wilson AP; Williams AH; Treasure T; Grüneberg RN
    Postgrad Med J; 1987 Aug; 63(742):621-4. PubMed ID: 2962071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin.
    Knudsen JD; Pedersen M
    Scand J Infect Dis; 1992; 24(3):395-6. PubMed ID: 1380722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin-induced neutropenia resolves after substitution with teicoplanin.
    Sanche SE; Dust WN; Shevchuk YM
    Clin Infect Dis; 2000 Sep; 31(3):824-5. PubMed ID: 11017842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetics of teicoplanin and vancomycin.
    Harding I; Sorgel F
    J Chemother; 2000 Nov; 12 Suppl 5():15-20. PubMed ID: 11131959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graded Dalbavancin Challenge in a Patient With Severe Vancomycin Hypersensitivity Reaction.
    Ishizuka KT; Tran TK; Ayars AG; Chau AS; Chan JD
    Clin Infect Dis; 2020 Mar; 70(6):1230-1232. PubMed ID: 31300814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
    Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A four-year-old child with teicoplanin allergy but no evidence of cross-reaction with vancomycin.
    de Vries E; van Weel-Sipman MH; Vossen JM
    Pediatr Infect Dis J; 1994 Feb; 13(2):167. PubMed ID: 8190551
    [No Abstract]   [Full Text] [Related]  

  • 38. [Glycopeptides (vancomycin, teicoplanin)].
    Furuta I; Kitahashi T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():423-6. PubMed ID: 15658354
    [No Abstract]   [Full Text] [Related]  

  • 39. Vancomycin-Induced Leukocytoclastic Vasculitis: A Rare Case Report.
    Sharma P; Sharma E; Neupane SP; Dahal S; Dahal S
    J Investig Med High Impact Case Rep; 2018; 6():2324709618820873. PubMed ID: 30622993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case of Teicoplanin-Induced Pancytopenia Caused by Excessive Dosing.
    Choi HM; Choi MH; Yang YW
    Am J Ther; 2016; 23(1):e307-10. PubMed ID: 24263159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.